The Conafay Group
Consultancy founded in 2004 that advises life sciences organizations, academic institutions, and coalitions on engaging the U.S. federal government to advance healthcare research, secure non-dilutive funding, and shape policy. The firm provides strategy and operational support across federal R&D programs, coalition building, grantsmanship, and government relations. Public-facing summaries state the firm helped secure $80 million in client funding in 2024 and an additional $60 million by mid-2025.
Industries
N/A
Nr. of Employees
small (1-50)
Services
Strategic counsel and direct engagement with Congress and federal agencies to influence policy, appropriations, and program priorities relevant to life sciences clients.
Identification of federal and other non-dilutive funding opportunities, proposal development, grant writing, and submission support to secure R&D funding.
Creating and managing coalitions to coordinate advocacy, align stakeholder messaging, and advance shared funding or policy goals.
Support for universities and research centers to grow federally-funded programs via proposal alignment, peer review navigation, and institutional strategy.
Training programs and systems for organizations to build internal grant research and proposal writing capabilities.
Strategic counsel and direct engagement with Congress and federal agencies to influence policy, appropriations, and program priorities relevant to life sciences clients.
Identification of federal and other non-dilutive funding opportunities, proposal development, grant writing, and submission support to secure R&D funding.
Creating and managing coalitions to coordinate advocacy, align stakeholder messaging, and advance shared funding or policy goals.
Support for universities and research centers to grow federally-funded programs via proposal alignment, peer review navigation, and institutional strategy.
Training programs and systems for organizations to build internal grant research and proposal writing capabilities.
Expertise Areas
- Federal funding strategy and grant acquisition
- Government relations and legislative engagement
- Coalition building and stakeholder alignment
- Academic research program development
Key Technologies
- AI-driven biological pathway analysis
- Diagnostics and biosurveillance systems
- Medical product development support (drugs, biologics, devices, diagnostics)
- Clinical trial and translational research support
News & Updates
Webinar summarizing federal funding opportunities from agencies including BARDA, NIH, and DoD related to COVID-19 research and solutions.
Earlier webinar (March 30, 2020) presenting current and upcoming federal funding opportunities related to COVID-19 from BARDA, NIH, and DoD.
The firm reports helping clients secure $80 million in funding in 2024.
The firm reports supporting an additional $60 million in funding efforts by mid-2025.
Webinar summarizing federal funding opportunities from agencies including BARDA, NIH, and DoD related to COVID-19 research and solutions.
Earlier webinar (March 30, 2020) presenting current and upcoming federal funding opportunities related to COVID-19 from BARDA, NIH, and DoD.
The firm reports helping clients secure $80 million in funding in 2024.
The firm reports supporting an additional $60 million in funding efforts by mid-2025.